These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37719847)

  • 21. Structural modification of 4, 5-dihydro-[1, 2, 4] triazolo [4, 3-f] pteridine derivatives as BRD4 inhibitors using 2D/3D-QSAR and molecular docking analysis.
    Tong JB; Luo D; Feng Y; Bian S; Zhang X; Wang TH
    Mol Divers; 2021 Aug; 25(3):1855-1872. PubMed ID: 33392965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined 3D-QSAR modeling and molecular docking study on quinoline derivatives as inhibitors of P-selectin.
    Zeng H; Cao R; Zhang H
    Chem Biol Drug Des; 2009 Dec; 74(6):596-610. PubMed ID: 19843078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
    Chaube U; Bhatt H
    Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3D-QSAR, molecular docking, molecular dynamics, and ADME/T analysis of marketed and newly designed flavonoids as inhibitors of Bcl-2 family proteins for targeting U-87 glioblastoma.
    Poustforoosh A; Faramarz S; Nematollahi MH; Hashemipour H; Tüzün B; Pardakhty A; Mehrabani M
    J Cell Biochem; 2022 Feb; 123(2):390-405. PubMed ID: 34791695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking.
    Sun G; Fan T; Zhang N; Ren T; Zhao L; Zhong R
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27347909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. QSAR Studies of New Pyrido[3,4-
    Deokar H; Deokar M; Wang W; Zhang R; Buolamwini JK
    Med Chem Res; 2018 Dec; 27(11-12):2466-2481. PubMed ID: 31360052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
    Buolamwini JK; Assefa H
    J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2D and 3D-QSAR analysis of pyrazole-thiazolinone derivatives as EGFR kinase inhibitors by CoMFA and CoMSIA.
    Pourbasheer E; Aalizadeh R; Shiri HM; Banaei A; Ganjali MR
    Curr Comput Aided Drug Des; 2015; 11(4):292-303. PubMed ID: 26548551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Modeling Study for the Design of Novel Peroxisome Proliferator-Activated Receptor Gamma Agonists using 3D-QSAR and Molecular Docking.
    Jian Y; He Y; Yang J; Han W; Zhai X; Zhao Y; Li Y
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473866
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Akabli T; Toufik H; Lamchouri F
    J Biomol Struct Dyn; 2022 Jun; 40(9):3965-3978. PubMed ID: 33252029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast growth factor receptor (FGFR) inhibitors as anticancer agents: 3D-QSAR, molecular docking and dynamics simulation studies of 1, 6-naphthyridines and pyridopyrimidines.
    Modh DH; Modi SJ; Deokar H; Yadav S; Kulkarni VM
    J Biomol Struct Dyn; 2023 May; 41(8):3591-3606. PubMed ID: 35318898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors.
    Patel PD; Patel MR; Kaushik-Basu N; Talele TT
    J Chem Inf Model; 2008 Jan; 48(1):42-55. PubMed ID: 18076152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QSAR modeling and in silico design of small-molecule inhibitors targeting the interaction between E3 ligase VHL and HIF-1α.
    Pan J; Zhang Y; Ran T; Xu A; Qiao X; Yin L; Zhou W; Zhu L; Zhao J; Lu T; Chen Y; Jiang Y
    Mol Divers; 2017 Aug; 21(3):719-739. PubMed ID: 28689235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, Molecular Docking, and 2D-QSAR Modeling of Quinoxaline Derivatives as Potent Anticancer Agents against Triple-negative Breast Cancer.
    Kaushal T; Khan S; Fatima K; Luqman S; Khan F; Negi AS
    Curr Top Med Chem; 2022; 22(10):855-867. PubMed ID: 35331094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. QSAR Research of Novel Tetrandrine Derivatives against Human Hepatocellular Carcinoma.
    Wang M; Qiu B; Wang W; Li X; Huo H
    Anticancer Agents Med Chem; 2023; 23(19):2146-2153. PubMed ID: 37653634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Topological, Electronic, Geometrical, Constitutional and Quantum Chemical Based Descriptors in QSAR: mPGES-1 as a Case Study.
    Gupta A; Kumar V; Aparoy P
    Curr Top Med Chem; 2018; 18(13):1075-1090. PubMed ID: 30027847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simple and robust model to predict the inhibitory activity of α-glucosidase inhibitors through combined QSAR modeling and molecular docking techniques.
    Izadpanah E; Riahi S; Abbasi-Radmoghaddam Z; Gharaghani S; Mohammadi-Khanaposhtanai M
    Mol Divers; 2021 Aug; 25(3):1811-1825. PubMed ID: 33565001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-combined 3D-QSAR, docking molecular and ADMET prediction of 5-azaindazole derivatives as LRRK2 tyrosine kinase inhibitors.
    Khamouli S; Belaidi S; Ouassaf M; Lanez T; Belaaouad S; Chtita S
    J Biomol Struct Dyn; 2022 Feb; 40(3):1285-1298. PubMed ID: 32964807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2D- and 3D-QSAR modelling, molecular docking and
    Shukla A; Tyagi R; Meena S; Datta D; Srivastava SK; Khan F
    J Biomol Struct Dyn; 2020 Jan; 38(1):168-185. PubMed ID: 30686140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular modelling of quinoline derivatives as telomerase inhibitors through 3D-QSAR, molecular dynamics simulation, and molecular docking techniques.
    Vishwakarma K; Bhatt H
    J Mol Model; 2021 Jan; 27(2):30. PubMed ID: 33415518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.